Table 4.

Relationships between clinicopathologic features and expressions of VEGF-A, VEGF-C, and VEGF-D

VEGF-AVEGF-CVEGF-D
Sex
    Male27.5 (21.3-43.5)30.5 (19.2-43.1)27.9 (19.3-41.2)
    Female35.3 (23.9-44.9)25.3 (15.0-40.1)28.7 (20.4-40.0)
    P0.4390.2640.895
Age (y)
    ≤7027.5 (22.4-43.3)30.5 (19.0-42.3)26.1 (19.0-38.2)
    >7032.3 (21.2-44.3)30.2 (18.0-45.2)28.4 (20.0-42.4)
    P0.8950.9830.313
Multicentricity
    Absence38.6 (23.5-47.3)29.4 (18.7-44.6)27.1 (19.9-41.2)
    Presence37.2 (24.0-43.3)30.9 (16.3-42.3)29.1 (18.9-40.2)
    P0.6790.9880.925
pT stage
    Low28.5 (22.1-36.0)29.9 (17.3-40.8)27.5 (19.1-38.2)
    High39.7 (20.9-48.8)35.5 (24.8-48.3)39.5 (25.1-52.1)
    P0.0230.0430.030
Grade
    Low25.4 (21.1-36.0)26.8 (15.0-32.8)26.1 (19.3-36.0)
    High42.1 (24.9-47.1)38.6 (26.3-52.8)37.1 (21.9-42.4)
    P<0.001<0.0010.02